IND SWIFT LABORATORIES LT (INDSWFTLAB) financials

IND SWIFT LABORATORIES LT (INDSWFTLAB) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1995, Ind-Swift LaboratoriesLtd is a pharmaceutical company focusedon finished dosage formulations (FDF). Co. manufactures tablets, capsules, ointments, injectables, liquids and dry syrups across therapies including gynaecology, paediatrics, cardiology, diabetology and dermatology. Operations span domestic formulationsand international markets through ownbrands, contract manufactu…

Market Cap: ₹3,151Cr.
Current Price: ₹362
Stock P/E: 47.2
ROE: 4.01%
ROCE: 4.86%
Book Value: ₹158
Dividend Yield: 0.00%
52W High / Low: ₹425/87.0

In Jun 2026, IND SWIFT LABORATORIES LT (INDSWFTLAB) reported sales ₹186 Cr and net profit ₹24 Cr.

Annual TTM: sales ₹662 Cr, net profit ₹59 Cr.

Shareholding: Promoters 42.93% (Sep 2026), FIIs 10.78% (Sep 2026), DIIs 0.20% (Sep 2026), Public 46.09% (Sep 2026), No. of Shareholders 42,667% (Sep 2026).

INDSWFTLAB quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	3	122	150	148	150	153	173	186
Expenses	15	122	158	145	148	144	152	153
Operating Profit	-12	-1	-9	3	2	9	20	33
OPM %	-443%	-0.8%	-6%	2.1%	1.4%	6%	12%	18%
Other Income	13	16	216	15	18	18	-3	7
Interest	0	10	-27	1	2	1	-2	1
Depreciation	0	6	7	7	7	9	8	8
Profit before tax	0	-1	226	10	11	18	12	32
Tax %	0%	0%	4%	17%	21%	39%	-27%	25%
Net Profit	0	-1	218	8	9	11	15	24
EPS in Rs	0.05	-0.15	35.98	1.34	1.07	1.32	1.72	2.81
Raw PDF	—	—	—	—	—	—	—	—

INDSWFTLAB profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	752	857	988	1,152	1,673	562	636	662
Expenses	610	676	788	930	1,371	563	589	598
Operating Profit	142	180	200	222	302	-0	46	65
OPM %	19%	21%	20%	19%	18%	-0.1%	7%	10%
Other Income	36	23	34	7	476	292	36	40
Interest	107	100	96	92	104	3	1	1
Depreciation	90	87	131	57	80	24	31	31
Profit before tax	-20	16	8	79	594	264	50	73
Tax %	6%	127%	171%	46%	10%	3%	15%	—
Net Profit	-21	-4	-6	42	536	256	43	59
EPS in Rs	-3.52	-0.74	-0.97	7.19	90.74	42.25	4.90	6.92
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	—

INDSWFTLAB balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	48	60	60	60	60	67	69	87
Reserves	542	585	579	573	616	731	1,095	1,284
Borrowings	1,148	1,031	996	944	854	214	30	18
Other Liabilities	174	184	182	226	259	396	228	266
Total Liabilities	1,913	1,860	1,817	1,803	1,788	1,408	1,422	1,654
Fixed Assets	913	843	752	630	587	192	273	304
CWIP	20	11	19	10	8	51	0	12
Investments	26	26	55	111	85	167	269	330
Other Assets	953	979	991	1,052	1,108	998	880	1,008
Total Assets	1,913	1,860	1,817	1,803	1,788	1,408	1,422	1,654

INDSWFTLAB cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-75	123	135	136	183	-166	-45	-40
Cash from Investing Activity	-2	-10	-10	3	-14	-28	-110	-100
Cash from Financing Activity	100	-133	-124	-140	-168	658	77	145
Net Cash Flow	23	-20	1	-1	1	464	-78	5
Free Cash Flow	-90	112	131	123	170	-229	-71	-127
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	-60%	87%	75%	68%	82%	-55%	9,682%	-72%

INDSWFTLAB shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	42.01%	40.94%	40.94%	39.49%	39.49%	43.00%	42.93%	42.93%
FIIs	0.46%	3.07%	4.27%	14.80%	14.33%	13.88%	10.70%	10.78%
DIIs	0.94%	0.91%	0.91%	0.68%	0.68%	0.00%	0.17%	0.20%
Public	56.61%	55.08%	53.88%	45.02%	45.50%	43.14%	46.19%	46.09%
No. of Shareholders	28,752	28,117	28,709	43,780	42,121	39,222	40,881	42,667

INDSWFTLAB key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	168	187	171	158	149	56	104	108
Inventory Days	302	330	304	303	253	28	137	184
Days Payable	110	122	106	120	114	114	141	185
Cash Conversion Cycle	359	395	368	342	287	-30	100	107
Working Capital Days	225	256	243	249	226	-7	83	113
ROCE %	4%	5%	7%	7%	13%	21%	1%	5%

INDSWFTLABUpdated 16 Oct 2026, 12:01

Ind Swift Laboratories Lt

INDSWFTLABUpdated 16 Oct 2026, 12:01

Market Cap

₹3,151Cr.

Current Price

₹362

High / Low

₹425/87.0

Stock P/E

47.2

ROE4.01%

ROCE4.86%

Book Value₹158

Face Value₹10.0

Dividend Yield0.00%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	299	20	239	6	14	31	45	17	2.89
Sep 2023	270	21	207	7	13	36	17	30	5.09
Dec 2023	276	21	222	7	14	27	19	22	3.66
Mar 2024	517	3	430	458	20	523	6	491	83.05
Jun 2024	30	0	35	11	0	6	0	6	1.05
Sep 2024	3	0	15	13	0	0	0	0	0.05
Dec 2024	122	10	122	16	6	-1	0	-1	-0.15
Mar 2025	150	-27	158	216	7	226	4	218	35.98
Jun 2025	148	1	145	15	7	10	17	8	1.34
Sep 2025	150	2	148	18	7	11	21	9	1.07
Dec 2025	153	1	144	18	9	18	39	11	1.32
Mar 2026	173	-2	152	-3	8	12	-27	15	1.72
Jun 2026	186	1	153	7	8	32	25	24	2.81

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	646	117	557	-31	84	-143	-17	-119	-29.09
Mar 2016	639	106	532	1	85	-83	-29	-59	-14.37
Mar 2017	694	88	589	15	88	-56	-29	-40	-8.88
Mar 2018	731	28	604	16	87	29	38	18	3.89
Mar 2019	724	92	599	130	104	59	35	39	8.11
Mar 2020	752	107	610	36	90	-20	6	-21	-3.52
Mar 2021	857	100	676	23	87	16	127	-4	-0.74
Mar 2022	988	96	788	34	131	8	171	-6	-0.97
Mar 2023	1152	92	930	7	57	79	46	42	7.19
Mar 2024	1673	104	1371	476	80	594	10	536	90.74
Mar 2025	562	3	563	292	24	264	3	256	42.25
Mar 2026	636	1	589	36	31	50	15	43	4.9
TTM	662	1	598	40	31	73	—	59	6.92

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	42.93%
FIIs	10.78%
DIIs	0.2%
Public	46.09%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public
Dec 2023	42.01%	0.31%	18.73%	—	38.96%
Mar 2024	42.01%	0.26%	8.03%	—	49.72%
Jun 2024	42.01%	1.27%	0.94%	—	55.81%
Sep 2024	42.01%	0.65%	0.94%	—	56.41%
Dec 2024	42.01%	0.46%	0.94%	—	56.61%
Mar 2025	40.94%	3.07%	0.91%	—	55.08%
Jun 2025	40.94%	4.27%	0.91%	—	53.88%
Sep 2025	39.49%	14.8%	0.68%	—	45.02%
Dec 2025	39.49%	14.33%	0.68%	—	45.5%
Mar 2026	43%	13.88%	0%	—	43.14%
Jun 2026	42.93%	10.7%	0.17%	—	46.19%
Sep 2026	42.93%	10.78%	0.2%	—	46.09%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	42	551	1413	233	2238	1114	115	26	983	2238
Mar 2016	42	473	1457	238	2210	1095	82	26	1007	2210
Mar 2017	45	480	1242	353	2121	1042	70	26	982	2121
Mar 2018	46	497	1083	371	1997	934	69	26	968	1997
Mar 2019	48	542	1148	174	1913	913	20	26	953	1913
Mar 2020	60	585	1031	184	1860	843	11	26	979	1860
Mar 2021	60	579	996	182	1817	752	19	55	991	1817
Mar 2022	60	573	944	226	1803	630	10	111	1052	1803
Mar 2023	60	616	854	259	1788	587	8	85	1108	1788
Mar 2024	67	731	214	396	1408	192	51	167	998	1408
Mar 2025	69	1095	30	228	1422	273	0	269	880	1422
Mar 2026	87	1284	18	266	1654	304	12	330	1008	1654

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	100	-37	-64	0
Mar 2016	80	-30	-48	3
Mar 2017	93	-31	-69	-7
Mar 2018	71	-17	-62	-8
Mar 2019	-75	-2	100	23
Mar 2020	123	-10	-133	-20
Mar 2021	135	-10	-124	1
Mar 2022	136	3	-140	-1
Mar 2023	183	-14	-168	1
Mar 2024	-166	-28	658	464
Mar 2025	-45	-110	77	-78
Mar 2026	-40	-100	145	5

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	212	205	179	191	168	187	171	158	149	56	104	108
Inventory Days	319	377	317	305	302	330	304	303	253	28	137	184
Days Payable	119	137	88	112	110	122	106	120	114	114	141	185
Cash Conversion Cycle	412	445	409	384	359	395	368	342	287	-30	100	107
Working Capital Days	32	-35	-106	-59	225	256	243	249	226	-7	83	113
ROCE %	1%	2%	2%	3%	4%	5%	7%	7%	13%	21%	1%	5%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of IND SWIFT LABORATORIES LT (INDSWFTLAB)?

The reported market capitalisation for IND SWIFT LABORATORIES LT (INDSWFTLAB) is ₹3,151Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of INDSWFTLAB?

The current price shown for IND SWIFT LABORATORIES LT (INDSWFTLAB) on Fincrux is ₹362 with a 52-week high/low of ₹425/87.0.

What is the P/E ratio of IND SWIFT LABORATORIES LT (INDSWFTLAB)?

The stock P/E for IND SWIFT LABORATORIES LT (INDSWFTLAB) is 47.2 on Fincrux, with ROE at 4.01% and ROCE at 4.86%.

What were INDSWFTLAB latest quarterly results?

For Jun 2026, IND SWIFT LABORATORIES LT (INDSWFTLAB) reported sales ₹186 Cr and net profit ₹24 Cr (figures in ₹ crore unless noted).

What are INDSWFTLAB annual sales and net profit?

For TTM, IND SWIFT LABORATORIES LT (INDSWFTLAB) shows sales of ₹662 Cr and net profit of ₹59 Cr on the Fincrux profit & loss statement.

Who owns IND SWIFT LABORATORIES LT (INDSWFTLAB)?

Latest shareholding for IND SWIFT LABORATORIES LT (INDSWFTLAB) on Fincrux: Promoters 42.93% (Sep 2026), FIIs 10.78% (Sep 2026), DIIs 0.20% (Sep 2026), Public 46.09% (Sep 2026), No. of Shareholders 42,667% (Sep 2026).

Where can I find IND SWIFT LABORATORIES LT (INDSWFTLAB) financials?

IND SWIFT LABORATORIES LT (INDSWFTLAB) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show INDSWFTLAB balance sheet and cash flow?

Yes. The IND SWIFT LABORATORIES LT (INDSWFTLAB) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 16 October 2026 at 12:01